Global Exanthema Market Size, Status and Forecast 2019-2025

Description

An exanthem or exanthema is a widespread rash usually occurring in children. An exanthem can be caused by toxins, drugs, or microorganisms, or can result from autoimmune disease.
Geographically, North America dominated the exanthema market and Asia Pacific is projected to have fastest growth, owing to rapidly increasing awareness levels, modernizing healthcare infrastructure and favourable government support in this region.
In 2018, the global Exanthema market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Exanthema status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Exanthema development in United States, Europe and China.

The key players covered in this study
Manus Aktteva Biopharma
Teva Pharmaceutical Industries
CIRON Drugs & Pharmaceuticals
Iol Chemicals and Pharmaceuticals
Mikart
Ranbaxy Laboratories
Hikma
Nexgen Pharma

Market segment by Type, the product can be split into
Rubeola
Rubella
Erythema Infectiosum
Roseola Infantum

Market segment by Application, split into
Hospitals and Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Exanthema status, future forecast, growth opportunity, key market and key players.
To present the Exanthema development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Exanthema are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

TABLE OF CONTENT

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Exanthema Market Size Growth Rate by Type (2014-2025)
1.4.2 Rubeola
1.4.3 Rubella
1.4.4 Erythema Infectiosum
1.4.5 Roseola Infantum
1.5 Market by Application
1.5.1 Global Exanthema Market Share by Application (2014-2025)
1.5.2 Hospitals and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Exanthema Market Size
2.2 Exanthema Growth Trends by Regions
2.2.1 Exanthema Market Size by Regions (2014-2025)
2.2.2 Exanthema Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Exanthema Market Size by Manufacturers
3.1.1 Global Exanthema Revenue by Manufacturers (2014-2019)
3.1.2 Global Exanthema Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Exanthema Market Concentration Ratio (CR5 and HHI)
3.2 Exanthema Key Players Head office and Area Served
3.3 Key Players Exanthema Product/Solution/Service
3.4 Date of Enter into Exanthema Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Exanthema Market Size by Type (2014-2019)
4.2 Global Exanthema Market Size by Application (2014-2019)

5 United States
5.1 United States Exanthema Market Size (2014-2019)
5.2 Exanthema Key Players in United States
5.3 United States Exanthema Market Size by Type
5.4 United States Exanthema Market Size by Application

6 Europe
6.1 Europe Exanthema Market Size (2014-2019)
6.2 Exanthema Key Players in Europe
6.3 Europe Exanthema Market Size by Type
6.4 Europe Exanthema Market Size by Application

7 China
7.1 China Exanthema Market Size (2014-2019)
7.2 Exanthema Key Players in China
7.3 China Exanthema Market Size by Type
7.4 China Exanthema Market Size by Application

8 Japan
8.1 Japan Exanthema Market Size (2014-2019)
8.2 Exanthema Key Players in Japan
8.3 Japan Exanthema Market Size by Type
8.4 Japan Exanthema Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Exanthema Market Size (2014-2019)
9.2 Exanthema Key Players in Southeast Asia
9.3 Southeast Asia Exanthema Market Size by Type
9.4 Southeast Asia Exanthema Market Size by Application

10 India
10.1 India Exanthema Market Size (2014-2019)
10.2 Exanthema Key Players in India
10.3 India Exanthema Market Size by Type
10.4 India Exanthema Market Size by Application

11 Central & South America
11.1 Central & South America Exanthema Market Size (2014-2019)
11.2 Exanthema Key Players in Central & South America
11.3 Central & South America Exanthema Market Size by Type
11.4 Central & South America Exanthema Market Size by Application

12 International Players Profiles
12.1 Manus Aktteva Biopharma
12.1.1 Manus Aktteva Biopharma Company Details
12.1.2 Company Description and Business Overview
12.1.3 Exanthema Introduction
12.1.4 Manus Aktteva Biopharma Revenue in Exanthema Business (2014-2019)
12.1.5 Manus Aktteva Biopharma Recent Development
12.2 Teva Pharmaceutical Industries
12.2.1 Teva Pharmaceutical Industries Company Details
12.2.2 Company Description and Business Overview
12.2.3 Exanthema Introduction
12.2.4 Teva Pharmaceutical Industries Revenue in Exanthema Business (2014-2019)
12.2.5 Teva Pharmaceutical Industries Recent Development
12.3 CIRON Drugs & Pharmaceuticals
12.3.1 CIRON Drugs & Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Exanthema Introduction
12.3.4 CIRON Drugs & Pharmaceuticals Revenue in Exanthema Business (2014-2019)
12.3.5 CIRON Drugs & Pharmaceuticals Recent Development
12.4 Iol Chemicals and Pharmaceuticals
12.4.1 Iol Chemicals and Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Exanthema Introduction
12.4.4 Iol Chemicals and Pharmaceuticals Revenue in Exanthema Business (2014-2019)
12.4.5 Iol Chemicals and Pharmaceuticals Recent Development
12.5 Mikart
12.5.1 Mikart Company Details
12.5.2 Company Description and Business Overview
12.5.3 Exanthema Introduction
12.5.4 Mikart Revenue in Exanthema Business (2014-2019)
12.5.5 Mikart Recent Development
12.6 Ranbaxy Laboratories
12.6.1 Ranbaxy Laboratories Company Details
12.6.2 Company Description and Business Overview
12.6.3 Exanthema Introduction
12.6.4 Ranbaxy Laboratories Revenue in Exanthema Business (2014-2019)
12.6.5 Ranbaxy Laboratories Recent Development
12.7 Hikma
12.7.1 Hikma Company Details
12.7.2 Company Description and Business Overview
12.7.3 Exanthema Introduction
12.7.4 Hikma Revenue in Exanthema Business (2014-2019)
12.7.5 Hikma Recent Development
12.8 Nexgen Pharma
12.8.1 Nexgen Pharma Company Details
12.8.2 Company Description and Business Overview
12.8.3 Exanthema Introduction
12.8.4 Nexgen Pharma Revenue in Exanthema Business (2014-2019)
12.8.5 Nexgen Pharma Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

Choose License Type

Checkout Inquiry Sample